logo

Hepatitis C

2nd HCV Policy Summit on the elimination of hepatitis C in Europe

Securing sustainable funding for Hepatitis C Virus elimination plans

Speakers

Speakers Image 1
Professor George V. Papatheodoridis, National and Kapodistrian University of Athens
Speakers Image 1
Professor George V. Papatheodoridis, National and Kapodistrian University of Athens
_speaker

George Papatheodoridis is a Professor in Medicine and Gastroenterology at the Medical School of the National and Kapodistrian University of Athens and Director of the Academic Gastroenterology Department of Laiko Hospital, Athens, Greece. He was trained in Medicine and completed his PhD thesis entitled “Acute on Chronic Hepatitis B” at the Medical School of Athens University. He was trained in Gastroenterology at Tzaneion Hospital of Piraeus, Greece and had a 2-year research fellowship in Hepatology at the Royal Free Hospital of London, UK.

He served as member of the Scientific Committee/Governing Board of EASL and is member of EASL and AASLD (fellow). He is president of the Hellenic Association for Study of Liver, president of Hellenic Foundation of Gastroenterology & Nutrition, chair of the Scientific Committee for Viral Hepatitis of Hellenic Center for Prevention of Diseases and chair of the committee for the implementation of the Hellenic National Plan for hepatitis C elimination. He was general secretary of Hellenic Society of Gastroenterology and Hellenic Association for the Study of Liver.

His main research interest has been focused on viral hepatitis. He has co-authored >260 papers published in PubMed journals with a total IF>1600 and >11000/17500 citations (h-index 52/65) in Scopus/Google Scholar. He was Associate Editor of Liver International and has served as Editorial Board member of other international journals and as reviewer for all gastroenterology/hepatology journals, many major internal medicine journals (New Engl J Med, Lancet, Ann Intern Med, BMJ etc), ILC/EASL-UEGW abstracts, EU 7th Framework Programme for research and Horizon 2020. He has given >130 lectures, chaired >45 lectures/round tables and presented >260 abstracts in international meetings.

Speakers Image 2
Homie Razavi, Managing Director, Centre for Disease Analysis Foundation
Speakers Image 2
Homie Razavi, Managing Director, Centre for Disease Analysis Foundation
_speaker

Homie Razavi is the managing director at the Center for Disease Analysis Foundation (CDAF).  His team has analyzed and published the hepatitis epidemiology data for over 100 countries and has worked with individual countries to develop national hepatitis strategies.  He leads the Polaris Observatory, which provides up to date estimates for HCV, HBV and HDV disease burden and the impact of strategies that meet national targets.  In addition, he is the founder of the Global Procurement Fund (GPRO), which provides affordable quality treatment and diagnostics to low and middle-income countries. 

He has a broad background, which includes basic research, business development, commercial development, portfolio management, and decision analysis. He is a fellow in the Society of Decision Professionals, an overseas fellow in the Royal Society of Medicine, and a member of AASLD and EASL.  He is also a member of the World Hepatitis Alliance (WHA) and the CDA Foundation board of directors. 

Speakers Image 3
Prof Jeffrey V. Lazarus, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic, University of Barcelona, and CHIP, University of Copenhagen
Speakers Image 3
Prof Jeffrey V. Lazarus, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic, University of Barcelona, and CHIP, University of Copenhagen
_speaker

Prof Jeffrey V. Lazarus is on the faculty of the Barcelona Institute of Global Health (ISGlobal), Hospital Clínic, University of Barcelona, and CHIP, the WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. Prior to that, his decade-long career as a health systems and communicable diseases expert at WHO’s Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

He is a founding steering committee member of the multi-stakeholder ACHIEVE hepatitis elimination initiative (2017), the HIV in Europe Initiative (2007) and the HIV Outcomes Beyond Viral Suppression coalition (2016). He also serves as the Board Chair of the foundation AFEW International, a Board member of the EASL International Liver Foundation, and a steering committee member of the European Commission’s two Joint Actions on HIV, hepatitis and other coinfections. He is the author of more than 200 publications. In 2017, he was awarded The Economist Intelligence Unit Hepatitis C Changemaker award.

Speakers Image 4
Michael P. Manns, MD Hannover Medical School, Hannover, Germany
Speakers Image 4
Michael P. Manns, MD Hannover Medical School, Hannover, Germany
_speaker

Michael P. Manns is Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School (MHH), Hannover, Germany since 1991. Since 2015 he is also Clinical Director of the Helmholtz Centre for Infection Research (HZI), Braunschweig, and Founding Director of the Centre for Individualised Infection Medicine (CIIM), Hannover.

He graduated in medicine from the University of Vienna in Austria and the University of Mainz in Germany before completing postgraduate training at the Free University of Berlin, Germany, and the University of Mainz, where he became Professor of Medicine in 1986. Subsequently, Professor Manns was a Research Associate at the Scripps Research Institute in La Jolla, California, USA, from 1987 to 1988.

Professor Manns is founder and Chairman of Hep-Net, a national network of competence on viral hepatitis, and the German Liver Foundation. He has been President of the German Society of Gastroenterology (DGVS), the German Association for the Study of the Liver (GASL), the German Society of Internal Medicine (DGIM) and United European Gastro­enterology (UEG).

Since 2015 Prof. Manns is member of the Scientific Panel for Health (SPH) of the European Commission. Professor Manns has received numerous awards including the International Hans Popper Award in 1995 and the European Association for the Study of the Liver (EASL) Recognition Award in 2007.

Professor Manns has a long-term research interest in liver diseases with a main focus on viral hepatitis, autoimmune liver diseases, hepatocellular carcinoma, liver transplantation and regenerative medicine.

He has published more than 1000 articles in international peer-reviewed journals such as the New England Journal of Medicine, The Lancet, Nature, Nature Medicine, Cell, Gastroenterology, and Hepatology among others. He has an h-index of 153 (as of May 8, 2018). According to Thomson Reuters he ranks among the top 1 % of most cited researchers in clinical medicine.

Speakers Image 5
Ricardo Baptista Leite, MP, MD, PhD(c) | Member of Portuguese Parliament
Speakers Image 5
Ricardo Baptista Leite, MP, MD, PhD(c) | Member of Portuguese Parliament
_speaker

Member of the Portuguese Parliament, National Spokesperson for Health of the Social Democratic Party, Medical Doctor trained in infectious diseases and Head of Public Health at Católica University of Portugal. 

Under the auspices of UNAIDS, Ricardo is the Founder and President of ‘UNITE – Global Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and other Infectious Diseases’, a global platform of policy makers.

Awarded by ‘The Economist Intelligence Unit’ as a ‘HCV Change Maker’ (2016). This acknowledgment, attributed to solely six people globally, came in due recognition of Ricardo’s academic work and policy leadership in the field of hepatitis c. 

National Spokesperson for Health of the Social Democratic Party and Member of the Portuguese National Parliament, currently on a 2nd term (2011-Present). Serving as coordinator (PSD) of the Parliamentary Health Committee and permanent member of the Parliamentary Foreign Affairs Committee; having served as Vice-President of the Foreign Affairs Committee, permanent member of the Parliamentary group on Population and Development, Chair of the all-party Parliamentary HIV/AIDS workgroup and President of the Portuguese-Canadian Parliamentary Friendship Group.

Head of Public Health at the Institute of Health Sciences of Católica University of Portugal. Guest Lecturer at NOVA Medical School (Infectious Diseases and Microbiology) and at NOVA Information Management School (Coordinator of Sustainable Healthcare Unit), both at NOVA University. Senior Fellow at New Westminster College (BC, Canada) and PhD candidate in Public Health and Health Systems at Maastricht University (The Netherlands). Previous experience includes having been an elected member of the supervisory board of the National Genetic Database Protection Agency and a decade of experience in health technology as a medical consultant at Glintt Healthcare Solutions (2009-2016), a multinational software house.

From 2015 to 2017, Deputy Mayor and City Councilor of Cascais, responsible for local health policy, academic partnerships, international relations (including economic diplomacy), youth (including Cascais European Youth Capital 2018) and employment policies.  

In the past, practicing physician for 7 years, including a 5-year Infectious Diseases residency program at the Western Lisbon Hospital Center. Intern in public health (HIV, Hepatitis and STI’s) as a formal collaborator of the World Health Organization Regional Office for Europe, based in Copenhagen (2011). 

Post-graduate studies in many universities in Europe and abroad, among which are Johns Hopkins University (MD, USA), Harvard Medical School (MA, USA), Harvard Kennedy School of Government/IESE (Madrid, Spain), Albert Einstein College of Medicine (NY, USA), Universitat Autònoma de Barcelona (Spain) and AESE Business School (Lisbon, Portugal). 

Volunteer work related to health and development organizations, such as being member of the Center for Health and Development International Advisory Board (Mangalore, India), member of the Hepatitis B and C Public Policy Association (Luxembourg), among many other affiliations with Patient Associations

Fellow of the Millennium Fellowship at The Atlantic Council and of the Marshall Memorial Fellowship at the German Marshall Fund. Member of the European Leadership Network (www.europeanleadershipnetwork.org), European Young Leaders (Friends of Europe | Europanova), European Young Leaders Forum (BMW Foundation), Emerging Leaders in Environmental and Energy Policy Network (ELEEP | The Atlantic Council), Chatham House (The Royal Institute of International Affairs). Fellow at the ZEIT Stiftung - Fundação Gertúlio Vargas 2015 Latin American Forum on Global Governance and member of the ZEIT Stiftung alumni. Member of the Antigua Forum alumni at Universidad Francisco Marroquín (Guatemala).

Founder of CREATING HEALTH – Research and Innovation funding, a sustainable nonprofit which has been set up within the Católica University of Portugal to help capture funding for health innovation and research projects (http://creatinghealth.ics.lisboa.ucp.pt). 

Co-founder of the Estoril Conferences, which are focused on the issue of globalization under the motto Global Challenges, Local Answers (www.estorilconferences.com).

Main author of the book “Citizenship for Health (PT, 2015), which is focused on the role of Citizens in health promotion and disease prevention, and of the bookStrategic Consensus on Integrated Management of Hepatitis C in Portugal(PT, 2014), among other publications. 

 

Speakers Image 6
Prof. Malliori Minerva-Melpomeni, National and Kapodistrian University of Athens, Greece
Speakers Image 6
Prof. Malliori Minerva-Melpomeni, National and Kapodistrian University of Athens, Greece
_speaker

Meni Malliori is Professor of Psychiatry at the National and Kapodistrian University of Athens Medical School and she is working in Eginition Hospital. She worked as a Consultant in the Mental Health Department of the World Health Organization-Geneva (1987) and then she was President of the Greek Organization Against Drugs-OKANA during 1997-1999 and 2010-2013. After her first Presidency in OKANA she was elected as a Member in the European Parliament (1999-2004) working in the field of Public Health and after her mission she was Representative of the European Parliament in the European Centre for Disease Prevention and Control (2004-2016). She also acted as Vice President of the Greek Centre for Disease Prevention and Control (2008-2012) as well as Member of the Management Board of the European Monitoring Centre for Drugs and Drug Addiction (1997-1999 and 2010-2013).  

She has been involved in several projects on infectious diseases and was co-investigator in a large RDS programme in injecting drug users during an HIV outbreak in Athens. She is the author or coauthor of 83 papers published in peer-reviewed international journals.

Speakers Image 7
Angelos Hatzakis, MD, PhD, MSc, Professor of Epidemiology & Preventive Medicine
Speakers Image 7
Angelos Hatzakis, MD, PhD, MSc, Professor of Epidemiology & Preventive Medicine
_speaker

Angelos Hatzakis, MD, PhD, MSc, Professor of Epidemiology & Preventive Medicine, National & Kapodistrian University of Athens, Medical School, Founder and Co-Chair of Hepatitis B&C Public Policy Association

Angelos Hatzakis is the Founder of the National Retrovirus Reference Center in Athens, Greece and Founder and Co-Chair of the Hepatitis B & C Public Policy Association, Luxembourg. He is Former President of the Hellenic Center for Disease Control & Prevention.

Angelos Hatzakis has  participated in many Executive Committees of the private and public sector. His research interests cover epidemiology, virology, preventive medicine and Public Health of infectious diseases, especially HIV/AIDS, hepatitis and other oncogenic viruses with more than 290 international scientific publications and more than 13.000 citations.

Speakers Image 8
Jagpreet Chhatwal, Assistant Professor, Harvard Medical School, Boston, United States Senior Scientist, Massachusetts General Hospital, Boston, United States
Speakers Image 8
Jagpreet Chhatwal, Assistant Professor, Harvard Medical School, Boston, United States Senior Scientist, Massachusetts General Hospital, Boston, United States
_speaker

Jagpreet Chhatwal, PhD is an assistant professor at Harvard Medical School and a senior scientist at Massachusetts General Hospital. His research is centered in decision science, data analytics, and health economics. He has over 10 years of experience in developing simulation/mathematical models to evaluate disease outcomes. Dr. Chhatwal’s recent work on hepatitis C has informed several highly-debated questions surrounding the cost-effectiveness of hepatitis C screening and treatments. In partnership with the World Health Organization, he recently developed an online modeling tool, the Hep C Calculator, that allows policymakers from 28 countries to evaluate the cost-effectiveness of hepatitis C treatment in those countries. His work has been featured in leading media such as The Wall Street Journal, Forbes, and National Public Radio.

Speakers Image 9
Markus Peck-Radosavljevic, M.D., MBA, Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
Speakers Image 9
Markus Peck-Radosavljevic, M.D., MBA, Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
_speaker

Markus Peck-Radosavljevic, M.D., MBA Professor of Medicine Chair, Dept. of Internal Medicine and Gastroenterology (IMuG) Hepatology, Endocrinology, Rheumatology and Nephrology Centralized Emergency Service (ZAE) Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria 

Professor Markus Peck-Radosavljevic, MD MBA, is Professor of Medicine and Chairman at the Department of Gastroenterology & Hepatology, Endocrinology, Rheumatology and Nephrology at Klinikum Klagenfurt in Klagenfurt, Austria.  Prof. Peck is a graduate of the Medical University of Graz Medical School, did his research training Medical University of Graz, University of Alberta in Edmonton Canada, Baylor College of Medicine in Houston Texas, and completed his clinical training in Internal Medicine, Gastroenterology/Hepatology, Infectious Diseases, and Intensive Care Medicine at the Medical University of Vienna, Austria.  He began his research in liver disease in the field of portal hypertension and he has been running a translational lab testing novel approaches to the treatment of portal hypertension and HCC for many years, while working at the Medical University of Vienna. He has been actively involved in the management of post-OLT hepatitis C and has been running clinical trials in HCV-infection in hemodialysis patients and HIV-HCV coinfection.  Professor Peck  served as Vice-secretary of EASL from 2011 to 2013 and as Secretary General of EASL from April 2013 to April 2015. He also served as the Secretary General of the Austrian Association for Internal Medicine from 2006-2014. He is member of the UEG Council since 2015 and Chair of the United European Gastroenterology (UEG) Public Affairs Committee (PAC), which he took over in 2018.  For many years until the end of 2015, Professor Peck lead the Portal Hypertension, the HIV-HCV-Coinfection, and the Hepatocellular Carcinoma (HCC) Study Groups at the Medical University of Vienna, Austria, where he has conducted a number of clinical trials in these indications as well as on new antivirals in HCV-infection in special indications. Since January 2016, he has taken over as Chair of Internal Medicine and Gastroenterology in Klagenfurt, which also includes the Endocrinology, the Rheumatology, the Nephrology (including Hemodialysis) and the Emergency Medicine service. He has set up a new Clinical trials study unit there and is running a broad range of clinical trials in various different indications, including HCC, NASH, and Hepatitis C.  

Speakers Image 10
Prof. Francesco NEGRO, University Hospitals, Geneva, Switzerland
Speakers Image 10
Prof. Francesco NEGRO, University Hospitals, Geneva, Switzerland
_speaker

Francesco Negro is Professor at the Departments of Specialty Medicine and of Pathology and Immunology of the University of Geneva, Switzerland. Professor Negro has a long-lasting research interest in viral hepatitis, focusing his work on the pathogenesis of metabolic alterations induced by the hepatitis C virus, especially steatosis and insulin resistance. More recently, he has participated into several collaborative works on epidemiology and public health issues related to viral hepatitis, such as the Polaris Observatory and the HEPAHEALTH project. He has participated in several clinical trials in acute and chronic HCV, authoring or co-authoring about 300 peer-reviewed manuscripts in the field of hepatology.

 

He has been member of the Editorial Board of several international journals in the field of hepatology (Journal of Hepatology, Gut, Liver International, European Journal of Gastroenterology and Hepatology), and of the scientific advisory board of the Agence Nationale de la Recherche sur le SIDA et les Hépatites (ANRS). He has a strong interest also in educational activities in the field of hepatology, being member of the Faculty of UpToDateTM and Clinical Care Options inPracticeTM, having developed the iLiverTM smartphone application for the European Association for the Study of the Liver (EASL), and having served for three years as Educational Councilor for EASL and within the United European Gastroenterology Educational Committee. He is currently Co-Editor of Liver International, Chairman of the Swiss Hepatitis C Cohort Study, and Treasurer-elect of the EASL. Finally, he is member of the updating committees of the clinical practice guidelines for HCV of the EASL and the World Health Organisation.

 

Speakers Image 11
Prof Yazdan Yazdanpanah, Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology, Head of an Inserm team on decision analysis in Infectious Diseases, and Professor of Medicine at Paris Diderot University, France ; Head of Infectious Disease department at Bichat Claude Bernard Hospital.
Speakers Image 11
Prof Yazdan Yazdanpanah, Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology, Head of an Inserm team on decision analysis in Infectious Diseases, and Professor of Medicine at Paris Diderot University, France ; Head of Infectious Disease department at Bichat Claude Bernard Hospital.
_speaker

Prof Yazdan Yazdanpanah, Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology, Head of an Inserm team on decision analysis in Infectious Diseases, and Professor of Medicine at Paris Diderot University, France ; Head of Infectious Disease department at Bichat Claude Bernard Hospital.

Yazdan Yazdanpanah is currently the head of an Inserm team on decision analysis in Infectious Diseases, the Head of Infectious Disease department at Bichat Claude Bernard Hospital, and Professor of Medicine at Paris Diderot University, France. Yazdan Yazdanpanah graduated in Medicine at the Lille School of Medicine, France in 1996. He qualified at the same institution first as a hepato- gastro-enterologist in 1996 and later as an infectious disease specialist in 2002. He obtained a Master of Science degree in epidemiology from the Harvard School of Public Health, Boston, US in 2000, and a Ph.D degree in public health from the Bordeaux School of Public Health in 2002. In 2006, he became Professor of Infectious Disease.  His research interests include the clinical epidemiology of HIV and viral hepatitis, and the pharmaco-economics of antimicrobial agents. He is one of the coordinators of Inserm “REACTing », a network under the umbrella of Aviesan (REsearch and ACTion targeting emerging infectious disease) the goal of which is to optimize and coordinate the existing research capacities during emerging and re-emerging infection threats.  He was recently appointed Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology. Professor Yazdanpanah has published extensively in peer-reviewed journals and makes frequent presentations at numerous national and international meetings.

Speakers Image 12
David Tordrup, WHO Collaborating Centre for Pharmaceutical Policy and Regulation University of Utrecht, Netherlands
Speakers Image 12
David Tordrup, WHO Collaborating Centre for Pharmaceutical Policy and Regulation University of Utrecht, Netherlands
_speaker

David Tordrup, WHO Collaborating Centre for Pharmaceutical Policy and Regulation University of Utrecht, Netherlands                                          

David Tordrup is a health- and pharmaceutical economist with a background in life sciences. He is managing director of Triangulate Health Ltd, a consulting firm working closely with the private sector, non-governmental and multilateral organisations on health economic evidence generation. His past projects include economic modelling of infectious disease management programmes, systematic reviews, financing and policy analysis, and a range of other data-driven projects in health economics. He has previously supported WHO with costing studies for the TB, HIV and Hepatitis Action Plans of the EURO region, and is currently working with Dr. Yvan Hutin and colleagues at WHO HQ on a costing model for bringing hepatitis B and C services under universal health coverage. Prior to this, David worked at the World Health Organization in Brussels, where he managed and implemented the Research Agenda for Health Economic Evaluation project, and at the LSE where he contributed to several FP7 projects on Health Technology Assessment and on health system financial sustainability with Dr. Panos Kanavos. He is undertaking part-time doctoral research at the WHO Collaborating Centre for Pharmaceutical Policy and Regulation at the University of Utrecht, Netherlands, is acting as an external expert in health economics for the European Commission, and is an Associate Editor at the Journal of Pharmaceutical Policy and Practice, focusing on pharmaceutical policies in low/middle income countries. Prior to his career in health economics, David worked for almost 5 years in life sciences, specialising in diagnostics and drug targets for infectious diseases. 

Speakers Image 13
Zobair M. Younossi, MD, MD, MPH, FACG, AGAF, FAASLD Inova Fairfax Hospital, Virginia Commonwealth University, Inova Campus, George Mason University
Speakers Image 13
Zobair M. Younossi, MD, MD, MPH, FACG, AGAF, FAASLD Inova Fairfax Hospital, Virginia Commonwealth University, Inova Campus, George Mason University
_speaker

Zobair M. Younossi, MD, MD, MPH, FACG, AGAF, FAASLD Inova Fairfax Hospital,  Virginia Commonwealth University, Inova Campus,  George Mason University  

ZOBAIR M. YOUNOSSI, MD, MD, MPH, FACG, AGAF, FAASLD Chairman of the Department, Inova Fairfax Hospital  Professor of Medicine, Virginia Commonwealth University, Inova Campus  Affiliate Professor of Biomedical Sciences at George Mason University  

Zobair M. Younossi, MD, MPH is the Chairman of the Department, Inova Fairfax Hospital, and He is also       Professor of Medicine, Virginia Commonwealth University, Inova Campus and Affiliate Professor of Biomedical Sciences at George Mason University. 

Dr. Younossi earned his medical degree from the University of Rochester School of Medicine and Dentistry in Rochester, New York (Alpha Omega Alpha, 1989), and completed his residency in internal medicine as well as a fellowship in gastroenterology and hepatology at Scripps Clinic and Research Foundation in La Jolla,           California. During his residency and fellowship, he earned his master of public health degree from San Diego State University (SDSU) School of Public Health in San Diego, California, being awarded the Hanlon Award and Outstanding Student Award for SDSU. He then served as the Staff Hepatologist and Senior Researcher at the Cleveland Clinic Foundation, Cleveland, Ohio (1995-2000). 

Dr. Younossi specializes in hepatology and gastroenterology and has authored over 400 articles and 12 book chapters in his field. He has also presented over 600 abstracts at international meetings and over 300 faculty lectures. 

Dr. Younossi's experience in scientific publishing includes being associate editor for Evidence Based Gastroenterology, former associate editor of Liver International, and editorial board member and journal reviewer forHepatology. He also worked with many other journals in the areas of hepatology, gastroenterology, internal medicine, and with prominent publications such as The American Journal of Medicine and Journal of American Medical Association.

With financial support of

Official endorsements